ARTICLE
9 October 2017

Brazil Becomes Newest Member Of PPH Partner Offices

MI
Moeller IP Advisors

Contributor

Moeller IP Advisors logo
Moeller IP Advisors offers you 90 years of experience and IP expertise in Latin America. We specialize in providing a complete range of Intellectual Property and Regulatory Affair services throughout the Latin American region.
On October 4, 2017 the Brazilian PTO (INPI) and EPO signed the PPH agreement.
Brazil Intellectual Property
To print this article, all you need is to be registered or login on Mondaq.com.

On October 4, 2017 the Brazilian PTO (INPI) and EPO signed the PPH agreement.  The organizations were represented by Luiz Otávio Pimentel, the President of Brazil's National Institute of Industrial Property (INPI) and EPO President Benoît Battistelli.

The agreement provides for collaboration through a pilot program of Patent Prosecution Highway (PPH), which is one of the most widely used in the world for cooperation between patent offices. For this model of partnership between two countries/regions, the patent applicant may request that the examination of his application be expedited in one of the offices, after having been granted by the other.

Under the PPH pilot, which will initially run for two years, applicants whose claims have been found to be patentable by either the EPO or INPI may ask for accelerated processing of their corresponding applications that are pending before the other office. Further details regarding the program will be made available via the Offices' website closer to the implementation date foreseen for the beginning of 2018.

This is possible because the patent, to be granted, must be new all over the world and therefore this step of the exam is similar in every office. When considering the analysis of another country to make its decision, the examiner will have substantial time reduction in his analysis work.

In this cooperation between the INPI and the EPO, up to 300 patent applications per year may be included in the areas of Medical Technology and Chemistry (except drugs).

We will keep you updated on the further developments.

Source: https://www.epo.org

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More